Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

BACKGROUND: Dimethyl fumarate and fingolimod are oral disease modifying treatments (DMTs) that reduce relapse activity and slow disability worsening in relapsing–remitting multiple sclerosis (RRMS). OBJECTIVE: To compare the effectiveness of dimethyl fumarate and fingolimod in a real-world setting,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Neurol
Prif Awduron: Lorscheider, Johannes, Benkert, Pascal, Lienert, Carmen, Hänni, Peter, Derfuss, Tobias, Kuhle, Jens, Kappos, Ludwig, Yaldizli, Özgür
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Berlin Heidelberg 2020
Pynciau:
Original Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914245/
https://ncbi.nlm.nih.gov/pubmed/32974794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-020-10226-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg